Inventor · disambiguated record
Avi Ashkenazi
Also filed as: ASHKENAZI AVI · ASHKENAZI AVI J · BAKER KEVIN P · BOTSTEIN DAVID
78 granted patents·179 pending applications·1,625 citations·filing 1992–2023
99Inventor score
Top patents by PatentIndex Score
257 records- 0198US8030023B2Nucleic acid encoding DR5 antibodies and uses thereofGENENTECH INC·Filed 2006·Granted Oct 4, 2011·56 cites·8 claims
- 0298US6635468B2Secreted and transmembrane polypeptides and nucleic acids encoding the sameGENENTECH INC·Filed 2001·Granted Oct 21, 2003·92 cites·15 claims
- 0397US6342369B1Apo-2-receptorGENENTECH INC·Filed 1998·Granted Jan 29, 2002·127 cites·18 claims
- 0496US6252050B1Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the methodGENENTECH INC·Filed 1999·Granted Jun 26, 2001·149 cites·19 claims
- 0594US8029783B2DR5 antibodies and articles of manufacture containing sameGENENTECH INC·Filed 2006·Granted Oct 4, 2011·22 cites·42 claims
- 0694US7074592B2Secreted and transmembrane polypeptides nucleic acid encodingGENENTECH INC·Filed 2001·Granted Jul 11, 2006·29 cites·8 claims
- 0794US6746668B2Apo-2 ligandGENENTECH INC·Filed 2001·Granted Jun 8, 2004·40 cites·9 claims
- 0894US5329028ACarbohydrate-directed cross-linking reagentsGENENTECH INC·Filed 1992·Granted Jul 12, 1994·87 cites·13 claims
- 0993US8007798B2Treatment of complement-associated disordersGENENTECH INC·Filed 2005·Granted Aug 30, 2011·29 cites·47 claims
- 1093US7705195B2Screening methodGENENTECH INC·Filed 2003·Granted Apr 27, 2010·47 cites·34 claims
- 1193US7390879B2Secreted and transmembrane polypeptides and nucleic acids encoding the sameGENENTECH INC·Filed 2002·Granted Jun 24, 2008·36 cites·6 claims
- 1293US7314619B2Inducing apoptosis using anti-Apo-2 antibodiesGENENTECH INC·Filed 2001·Granted Jan 1, 2008·18 cites·33 claims
- 1393US6974689B1Nucleic acid encoding PRO211 polypeptidesGENENTECH INC·Filed 2001·Granted Dec 13, 2005·27 cites·8 claims
- 1493US6723535B2Secreted and transmembrane polypeptides and nucleic acids encoding the sameGENENTECH INC·Filed 2001·Granted Apr 20, 2004·14 cites·17 claims
- 1592US8710189B2Anti-FGFR3 antibodies and methods using sameGENENTECH INC·Filed 2012·Granted Apr 29, 2014·12 cites·10 claims
- 1692US8410250B2Anti-FGFR3 antibodies and methods using sameASHKENAZI AVI·Filed 2010·Granted Apr 2, 2013·23 cites·27 claims
- 1792US7419663B2Treatment of complement-associated disordersGENENTECH INC·Filed 2004·Granted Sep 2, 2008·33 cites·24 claims
- 1892US7094567B2Secreted and transmembrane polypeptides and nucleic acids encoding the sameGENENTECH INC·Filed 2001·Granted Aug 22, 2006·12 cites·10 claims
- 1992US6764679B2Antibodies to DcR3 Polypeptide, a TNFR HomologGENENTECH INC·Filed 2001·Granted Jul 20, 2004·38 cites·33 claims
- 2091US7595046B2Treatment of cancer using anti-Apo-2 antibodiesGENENTECH INC·Filed 2005·Granted Sep 29, 2009·4 cites·25 claims
- 2191US7192589B2Treatment of inflammatory disorders with STIgMA immunoadhesinsGENENTECH INC·Filed 2003·Granted Mar 20, 2007·36 cites·5 claims
- 2291US6838554B2Nucleic acids encoding proteins that stimulate the proliferation of t-lymphocytesGENENTECH INC·Filed 2001·Granted Jan 4, 2005·33 cites·10 claims
- 2391US6582928B1Carbohydrate-directed cross-linking reagentsGENENTECH INC·Filed 2000·Granted Jun 24, 2003·16 cites·17 claims
- 2491US6030945AApo-2 ligandGENENTECH INC·Filed 1996·Granted Feb 29, 2000·93 cites·22 claims
- 2590US10000571B2Anti-FGFR3 antibodies and methods using sameGENENTECH INC·Filed 2016·Granted Jun 19, 2018·6 cites·11 claims
- 2690US9499623B2Anti-FGFR3 antibodies and methods using sameGENENTECH INC·Filed 2015·Granted Nov 22, 2016·6 cites·24 claims
- 2790US7211400B2Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigensGENENTECH INC·Filed 2004·Granted May 1, 2007·26 cites·5 claims
- 2890US6664376B2Secreted and transmembrane polypeptides and nucleic acids encoding the sameGENENTECH INC·Filed 2001·Granted Dec 16, 2003·9 cites·11 claims
- 2990US6410708B1Nucleic acids encoding A-33 related antigen polypeptidesGENENTECH INC·Filed 1998·Granted Jun 25, 2002·71 cites·8 claims
- 3090US5889155ACarbohydrate-directed cross-linking reagentsGENENTECH INC·Filed 1995·Granted Mar 30, 1999·83 cites·18 claims
- 3188US7189529B2PRO792 nucleic acidsGENENTECH INC·Filed 2001·Granted Mar 13, 2007·13 cites·6 claims
- 3288US6046048AApo-2 ligandGENENTECH INC·Filed 1997·Granted Apr 4, 2000·57 cites·16 claims
- 3387US7592439B2Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the methodGENENTECH INC·Filed 2007·Granted Sep 22, 2009·5 cites·3 claims
- 3487US7300656B2Treatment of inflammatory bowel disease with IFN-gamma inhibitorsGENENTECH INC·Filed 2002·Granted Nov 27, 2007·23 cites·17 claims
- 3586US8409570B2Method of inducing apoptosis using anti-DR5 antibodiesADAMS CAMELLIA W·Filed 2011·Granted Apr 2, 2013·4 cites·16 claims
- 3686US7449176B2Treatment of inflammatory bowel disease with IFN-γ inhibitorsGENENTECH INC·Filed 2002·Granted Nov 11, 2008·20 cites·25 claims
- 3785US7196165B2PRO363 polypeptidesGENENTECH INC·Filed 2001·Granted Mar 27, 2007·6 cites·9 claims
- 3884US9161977B2Anti-FGFR3 antibodies and methods using sameGENENTECH INC·Filed 2013·Granted Oct 20, 2015·4 cites·11 claims
- 3984US7807153B2Apo-2 receptor agonist antibodiesGENENTECH INC·Filed 2003·Granted Oct 5, 2010·4 cites·52 claims
- 4084US7056736B2Secreted and transmembrane polypeptides and nucleic acids encoding the sameGENENTECH INC·Filed 2001·Granted Jun 6, 2006·9 cites·12 claims
- 4183US8092799B2Antibodies to Apo-2 receptor polypeptidesADAMS CAMELLIA W·Filed 2010·Granted Jan 10, 2012·2 cites·22 claims
- 4282US7741056B2Use of A33 antigens and JAM-ITGENENTECH INC·Filed 2007·Granted Jun 22, 2010·3 cites·4 claims
- 4382US7629136B2Assays and methods using biomarkersGENENTECH INC·Filed 2006·Granted Dec 8, 2009·6 cites·13 claims
- 4482US6558661B1Treatment of inflammatory bowel disease with IFN-γ inhibitorsGENENTECH INC·Filed 1993·Granted May 6, 2003·33 cites·28 claims
- 4580US11401333B2Anti-FGFR3 antibodies and methods using sameGENENTECH INC·Filed 2019·Granted Aug 2, 2022·1 cites·13 claims
- 4679US9925240B2Methods of treating and preventing cancer drug resistanceGENENTECH INC·Filed 2014·Granted Mar 27, 2018·2 cites·12 claims
- 4779US8097700B2TAT294 polypeptidesASHKENAZI AVI J·Filed 2010·Granted Jan 17, 2012·1 cites·10 claims
- 4879US6998116B1Apo-2 ligandGENENTECH INC·Filed 1999·Granted Feb 14, 2006·22 cites·8 claims
- 4978US10287356B2Anti-FGFR3 antibodies and methods using sameGENENTECH INC·Filed 2016·Granted May 14, 2019·1 cites·9 claims
- 5078US8088386B2Treatment of complement-associated disordersASHKENAZI AVI·Filed 2005·Granted Jan 3, 2012·3 cites·6 claims
Showing the top 50 of 257 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Avi Ashkenazi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →